Injectable quinolone formulations
CA 2239352 C · Owner: Ah Usa 42 Llc · Inventors: Boettner, Wayne Alan; Canning, Peter Connor
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Aqueous pharmaceutical solutions suitable for injection into a host having , improved injection site toleration comprise danofloxacin, or its pharmaceutically acceptable salts and a magnesium or zinc compound. The zinc compound in addition requires the presence of a co-solvent.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 13, 1996 and granted June 4, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 13, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 13, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.